MedPath

Cancer therapy as a potential trigger for genital polyneuropathy in breast an ovarian cancer patients

Conditions
Polyneuropathy of the genitals in breast and ovarian cancer patients.
Registration Number
DRKS00030894
Lead Sponsor
niversität zu Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
432
Inclusion Criteria

Patients with breast cancer or ovarian cancer.
- Patients who are receiving/have received at least 1 of the following cancer therapies: surgery, chemotherapy, radiation therapy, immunotherapy, anti-hormone therapy.
- During therapy or in follow-up care
- Polyneuropathy of the hands and/or feet

Exclusion Criteria

- Age under 18
- No polyneuropathy in hands and/or feet or no temporal correlation to cancer therapy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of this study is to find out whether, and if so how often, the symptom of polyneuropathy of the genitals occurs in addition to PNP of the hands/feet in patients after cancer therapy.
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life, improvement and maintenance of sexual activity and satisfaction, possible development of a conservative treatment option.
© Copyright 2025. All Rights Reserved by MedPath